EUVIMEDEUVIMED entdecken
Crossref

The Distribution of HR‐HPV E6/E7 DNA and mRNA by Histological Grade and the Clinical Performance for Detection of Cervical Cancer and Precancer

Ruoji Pi iD, Tingyuan Li, Hua Zhang, Hang Zhou, Yuan Yang, Yu Dai iD, Zeni Wu, Mingyue Jiang, Wen Chen iD, Lan Zhu iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Ruoji Pi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sc…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Oncogene Proteins, Viral, RNA, Messenger. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: This work was supported by National High Level Hospital Clinical Research Funding, 2022-PUMCH-D-003..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐risk human papillomavirus (HR‐HPV) testing, utilizing both DNA and RNA methods, offers enhanced sensitivity compared to cytology for detecting high‐grade cervical intraepithelial neoplasia (CIN2+). Meanwhile, HR‐HPV E6 and E7 mRNAs are more likely to differentiate the transient infection from the persistent than DNA. Aptima HPV can not only detect HPV mRNA but also HPV DNA though it is much more efficient at detecting HPV RNA than DNA. Currently, there are few studies on the distribution of HPV E6 and E7 mRNA and DNA in the same individual. It is interesting to compare the clinical performance of the Onclarity and Aptima HPV assays and to assess variations in viral load across different histological grades at both DNA and mRNA levels. The analysis included 1607 women (902 from a cervical cancer screening population and 705 inpatients and outpatients), with cervical cytological samples tested using the Aptima and Onclarity HPV assays. Both assays demonstrated high agreement for HPV types 18/45 and 16. Signal‐to‐cutoff (S/CO) values and Ct values for various HR‐HPV types increased with histological severity from normal tissue to cancer. Notably, HPV18 Ct values exceeded those for HPV16 and 45 in women with ≥ CIN1 lesions but decreased sharply in cancer cases. Across the screening population, both assays showed similar sensitivity and predictive values for detecting CIN2+ lesions. The area under the curve (AUC) for CIN2+ and CIN3+ detection in the study population was robust (CIN2+: 0.880, 0.863; CIN3+: 0.881, 0.863). The DNA level for various HR‐HPV types increased with histological severity from normal tissue to cancer, which might impact the performance of Aptima HPV assay. Both assays showed similar sensitivity and predictive values for detecting CIN2+ lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsOncogene Proteins, ViralRNA, MessengerSensitivity and SpecificityDNA, ViralHumansFemaleAdultMiddle AgedRNA, ViralUterine Cervical DysplasiaEarly Detection of CancerPapillomaviridaeViral LoadAgedYoung Adult

Stichwörter der Autor:innen

E6/E7 DNAE6/E7 mRNAcervical cancerhuman papillomavirusmolecular diagnostics

Substanzen

Oncogene Proteins, ViralRNA, MessengerDNA, ViralRNA, Viral

Autor:innen und Institutionen

  • Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
  • The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian,…
  • School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing, China.

ORCID-Profile: Ruoji Pi, Yu Dai, Wen Chen, Lan Zhu

Förderung

  • This work was supported by National High Level Hospital Clinical Research Funding, 2022-PUMCH-D-003.

Zitieren

APA

Pi, R., Li, T., Zhang, H., Zhou, H., Yang, Y., Dai, Y., Wu, Z., Jiang, M., Chen, W., & Zhu, L. (2024). The Distribution of HR‐HPV E6/E7 DNA and mRNA by Histological Grade and the Clinical Performance for Detection of Cervical Cancer and Precancer. Journal of Medical Virology. https://doi.org/10.1002/jmv.70026

Vancouver

Pi R, Li T, Zhang H, Zhou H, Yang Y, Dai Y, et al. The Distribution of HR‐HPV E6/E7 DNA and mRNA by Histological Grade and the Clinical Performance for Detection of Cervical Cancer and Precancer. Journal of Medical Virology. 2024. doi:10.1002/jmv.70026

BibTeX
@article{Pi2024,
  author = {Pi, Ruoji and Li, Tingyuan and Zhang, Hua and Zhou, Hang and Yang, Yuan and Dai, Yu and Wu, Zeni and Jiang, Mingyue and Chen, Wen and Zhu, Lan},
  title = {The Distribution of HR‐HPV E6/E7 DNA and mRNA by Histological Grade and the Clinical Performance for Detection of Cervical Cancer and Precancer},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70026}
}
Kostenlos starten →